A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor-naïve patients with metastatic uveal melanoma.

Authors: Joseph J Sacco, Justin C. Moser, Allison Betof Warner, Ryan J. Sullivan, Diwakar Davar, Alexander Noor Shoushtari, Richard D. Carvajal, Sapna Pradyuman Patel, Anthony M. Joshua, Jessica Cecile Hassel, Mark Navarro, Rahul Marpadga, Giuseppe Gullo, Marlana M. Orloff

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps9597

Source: Full article

---

Abstract

TPS9597